Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
KZIA
Stock Latest News
Company Announcements
Kazia’s Paxalisib Shows Potential in Glioblastoma Trial
6d ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics reports results from GBM-AGILE phase II/III study
6d ago
KZIA
Premium
The Fly
Kazia Therapeutics files to sell 1.1M ADSs for holders
21d ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Announces Executive Changes
22d ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics files to sell 88.5M ADSs for holders
2M ago
KZIA
Premium
The Fly
Kazia Therapeutics reports 180-day extension granted by Nasdaq
2M ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Granted Nasdaq Compliance Extension
2M ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics’ EVT801 Phase 1 clinical trial completes Phase 1 objectives
3M ago
KZIA
Premium
The Fly
Kazia Therapeutics licenses paxalisib to Sovargen
4M ago
KZIA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
EBS
CLDX
Premium
The Fly
Kazia announces early conclusion of two-part Phase I trial evaluating paxalisib
5M ago
KZIA
Premium
The Fly
Kazia Therapeutics files to sell 4.76M ADSs for holders
6M ago
KZIA
Premium
The Fly
Kazia Therapeutics files to sell 592K American Depositary Shares for holders
7M ago
KZIA
Premium
The Fly
Kazia Therapeutics sells 4.44M ADSs at 45c in registered direct offering
8M ago
KZIA
Premium
The Fly
Kazia Therapeutics signs LOI to develop and commenrcialize paxalisib
8M ago
KZIA
Premium
The Fly
Kazia Therapeutics receives non-compliance letter from NASDAQ
8M ago
KZIA
Premium
The Fly
Kazia Therapeutics to release PNOC022 clinical study abstract
8M ago
KZIA
Premium
The Fly
Kazia Therapeutics’ paxalisib shows effiacy in published melanoma study
8M ago
KZIA
Premium
The Fly
Kazia Therapeutics provides update from Phase 2 clinical trial of paxalisib
9M ago
KZIA
Premium
The Fly
Kazia Therapeutics reports data from ongoing Phase 1 EVT801 study
9M ago
KZIA
Premium
The Fly
Kazia Therapeutics announces intent to de-list from ASX
9M ago
KZIA
Premium
The Fly
Kazia Therapeutics trading halted, news pending
9M ago
KZIA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
